Prescient Therapeutics Ltd - ESG Rating & Company Profile powered by AI
Detailed ESG assessment of Prescient Therapeutics Ltd can be reached by signing in. The SDG assessment for Prescient Therapeutics Ltd represents the company's transparency towards the UN SDGs. The ESG rating includes 17 United Nations SDGs including: 'Clean Water & Sanitation', 'Decent Work & Economic Growth' and 'Life below Water'.
Prescient Therapeutics Ltd in the Pharmaceuticals industry gained a UN SDG ESG Transparency Score of 0.0; made up of an environmental score of 0.0, social score of 0.0 and governance score of 0.0.
0.0
Low ImpactEnvironmental
Social
Governance
Peer Group Comparison
| Rank | Company | SDG Transparency Score ⓘ | Performance |
|---|---|---|---|
| 1 | Caladrius Biosciences Inc | 8.0 | High |
| 1 | Can Fite Biopharma Ltd | 8.0 | High |
| ... | ... | ... | |
| 1967 | Hospira Inc | 0.3 | Low |
| 1967 | PRA Health Sciences Inc | 0.3 | Low |
| 1970 | Prescient Therapeutics Ltd | 0.0 | Low |
| 1970 | CSPC Innovation Pharmaceutical Co Ltd | 0.0 | Low |
| 1970 | CTC Bio Inc | 0.0 | Low |
| 1970 | Zyden Gentec Ltd | 0.0 | Low |
| 1970 | iNtRON Biotechnology Inc | 0.0 | Low |
| ... | ... | ... |
Frequently Asked Questions
Does Prescient Therapeutics Ltd have an accelerator or VC vehicle to help deliver innovation?
Sign up for free to unlockDoes Prescient Therapeutics Ltd disclose current and historical energy intensity?
Sign up for free to unlockDoes Prescient Therapeutics Ltd report the average age of the workforce?
Sign up for free to unlockDoes Prescient Therapeutics Ltd reference operational or capital allocation in relation to climate change?
Sign up for free to unlockDoes Prescient Therapeutics Ltd disclose its ethnicity pay gap?
Sign up for free to unlockDoes Prescient Therapeutics Ltd disclose cybersecurity risks?
Sign up for free to unlockDoes Prescient Therapeutics Ltd offer flexible work?
Sign up for free to unlockDoes Prescient Therapeutics Ltd have a long term incentive (LTI) executive compensation plan based on a measure of return on capital?
Sign up for free to unlockDoes Prescient Therapeutics Ltd disclose the number of employees in R&D functions?
Sign up for free to unlockDoes Prescient Therapeutics Ltd conduct supply chain audits?
Sign up for free to unlockDoes Prescient Therapeutics Ltd disclose incidents of non-compliance in relation to the health and safety impacts of products and services?
Sign up for free to unlockIs there a statment that there is no plan to expand their cement production? (for example: 'We have no current plans to add additional cement making capacity')
Sign up for free to unlockDoes Prescient Therapeutics Ltd conduct 360 degree staff reviews?
Sign up for free to unlockDoes Prescient Therapeutics Ltd disclose the individual responsible for D&I?
Sign up for free to unlockDoes Prescient Therapeutics Ltd disclose current and historical air emissions?
Sign up for free to unlockIs there a statment that there is no plan to expand their coal usage? (for example: 'We have no current plans to add additional coal powered electricity generation')
Sign up for free to unlockIs executive remuneration linked to climate performance?
Sign up for free to unlockDoes the Board describe its role in the oversight of climate-related risks and opportunities?
Sign up for free to unlockDoes Prescient Therapeutics Ltd disclose current and / or historical scope 2 emissions?
Sign up for free to unlockDoes Prescient Therapeutics Ltd disclose water use targets?
Sign up for free to unlockDoes Prescient Therapeutics Ltd have careers partnerships with academic institutions?
Sign up for free to unlockDid Prescient Therapeutics Ltd have a product recall in the last two years?
Sign up for free to unlockDoes Prescient Therapeutics Ltd disclose incidents of discrimination?
Sign up for free to unlockDoes Prescient Therapeutics Ltd allow for Work Councils/Collective Agreements to be formed?
Sign up for free to unlockHas Prescient Therapeutics Ltd issued a profit warning in the past 24 months?
Sign up for free to unlockDoes Prescient Therapeutics Ltd disclose parental leave metrics?
Sign up for free to unlockDoes Prescient Therapeutics Ltd disclose climate scenario or pathway analysis?
Sign up for free to unlockDoes Prescient Therapeutics Ltd disclose current and / or historical scope 1 emissions?
Sign up for free to unlockAre Operating Expesnses linked to emissions reduction?
Sign up for free to unlockDoes Prescient Therapeutics Ltd disclose the pay ratio of women to men?
Sign up for free to unlockDoes Prescient Therapeutics Ltd support suppliers with sustainability related research and development?
Sign up for free to unlockDoes Prescient Therapeutics Ltd disclose the number of operations that have been subject to human rights reviews or human rights impact assessments?
Sign up for free to unlockDoes Prescient Therapeutics Ltd reflect climate-related risks in its financial statements?
Sign up for free to unlockIs there a statment that there is no plan to expand their carbon intensite energy assets? (for example: 'We have no current plans to carry out further drilling for oil,')
Sign up for free to unlockIs Prescient Therapeutics Ltd involved in embryonic stem cell research?
Sign up for free to unlockDoes Prescient Therapeutics Ltd disclose GHG and Air Emissions intensity?
Sign up for free to unlockDoes Prescient Therapeutics Ltd disclose its waste policy?
Sign up for free to unlockDoes Prescient Therapeutics Ltd report according to TCFD requirements?
Sign up for free to unlockDoes Prescient Therapeutics Ltd disclose its policies for bribery, corruption, whistle-blower, conflict of interest?
Sign up for free to unlockDoes Prescient Therapeutics Ltd disclose energy use targets?
Sign up for free to unlockDoes Prescient Therapeutics Ltd disclose its Renewable Energy targets?
Subscription requiredAre emissions metrics verified by STBi?
Subscription requiredDoes Prescient Therapeutics Ltd have a policy relating to cyber security?
Sign up for free to unlockHave a different question?
Potential Risks for Prescient Therapeutics Ltd
These potential risks are based on the size, segment and geographies of the company.
Prescient Therapeutics Limited, a clinical stage oncology company, develops novel drugs for the treatment of various cancers in Australia. Its lead drug candidate is PTX-200, which is in Phase 2a clinical trial for HER2-negative breast cancer, Phase IB/2 clinical trial in relapsed and refractory AML, and Phase 1b in recurrent or persistent platinum-resistant ovarian cancer; and PTX-100, a RhoA inhibitor, for hematological and solid malignancies that focuses on cancers with Ras and RhoA mutations. It has a strategic collaboration with The University of Texas MD Anderson Cancer Center to develop blood cancer binder for OmniCAR. The company was formerly known as Virax Holdings Limited and changed its name to Prescient Therapeutics Limited in December 2014. Prescient Therapeutics Limited was incorporated in 1986 and is based in Melbourne, Australia.